Bulletin of Stomatology and Maxillofacial Surgery
ISSN 1829-006X
2025; 284–294
Shared with The Gufo

CLINICAL APPLICATIONS AND REGENERATIVE POTENTIAL OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN WOUND HEALING: A:LITERATURE REVIEW

Received: 2026-04-08 · Published: 2025-11-06

Shared article.
Original title
CLINICAL APPLICATIONS AND REGENERATIVE POTENTIAL OF DECELLULARIZED HUMAN AMNIOTIC MEMBRANE IN WOUND HEALING: A:LITERATURE REVIEW
Author
Jenny Indah Haryanti
Source journal
Bulletin of Stomatology and Maxillofacial Surgery
Published
2025-11-06
Licence
Creative Commons Attribution-NonCommercial 4.0 International
Original
https://doi.org/10.58240/1829006X-2025.21.10-284

Abstract

Background: Chronic and acute wounds continue to pose significant clinical and socioeconomic challenges, particularly when complicated by infection, ischemia, or delayed re-epithelialization. Decellularized human amniotic membrane (dHAM) has gained attention as a biological scaffold capable of supporting tissue regeneration due to its intrinsic biocompatibility, anti-inflammatory properties, and structural similarity to native extracellular matrix (ECM). Objective:This literature review examines the clinical evidence on the safety and effectiveness of dHAM in skin and soft tissue wound healing, focusing on decellularization methods, scaffold properties, and patient outcomes. Methods:A systematic search of PubMed, Scopus, and Web of Science was conducted using keywords such as “decellularized human amnion,” “scaffold,” and “wound healing.” Only human clinical studies involving dHAM were included; preclinical, animal, and fresh or cryopreserved amnion studies were excluded. Thirteen studies out of 278 met the inclusion criteria for qualitative analysis. Results: Decellularization via physical, chemical, and enzymatic methods effectively removed cells while preserving ECM structure and bioactivity. Clinically, dHAM promoted faster epithelialization and angiogenesis, reduced inflammation, and improved scar quality in various wound types. Most wounds achieved closure within two to four weeks, with less pain and exudate compared to conventional dressings. Furthermore, modified dHAM scaffolds containing bioactive agents or hydrogels showed enhanced tissue regeneration and vascularization. Conclusion: dHAM is a safe, versatile biomaterial that combines structural support with biological activity to accelerate organized wound healing. With standardized processing and additional clinical trials, dHAM holds significant promise as a component of advanced regenerative wound care.
1 / ? 100% Open in new tab Download Cite

Loading the full text…

Download Follow Updates